Unknown

Dataset Information

ACE Inhibitor/Angiotensin Receptor Blocker Use Patterns in Advanced CKD and Risk of Kidney Failure and Death.


ABSTRACT:

Rationale & objective

The use of renin-angiotensin system (RAS) inhibitors is standard of care in people with early to moderate chronic kidney disease (CKD). Less is known regarding the efficacy of RAS inhibitors in very advanced CKD. In this study, we describe patterns of use of RAS inhibitors and associations of these patterns of use with risk for CKD progression and mortality in patients with advanced CKD.

Study design

Propensity-matched cohort study.

Settings & participants

We identified 678 participants who were enrolled in the multicenter Chronic Renal Insufficiency Cohort (CRIC) Study with estimated glomerular filtration rates (eGFRs) < 30 mL/min/1.73 m2 at the baseline visit.

Exposure

Use of RAS inhibitors within the first year after the base

SUBMITTER: Arora N 

PROVIDER: S-EPMC7380396 | biostudies-literature | 2020 May-Jun

REPOSITORIES: biostudies-literature